Flemish Breast Cancer Screening Programme: 15 years of Key Performance Indicators (2002-2016)

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2019 Oct 30

PMID 31660890

Citations 8

Authors

M Goossens

I De Brabander

J De Greve

C Van Ongeval

P Martens

E Van Limbergen

E Kellen

Affiliations

Soon will be listed here.

Abstract

Background: We examined 15 years of key performance indicators (KPIs) of the population-based mammography screening programme (PMSP) in Flanders, Belgium.

Methods: Individual screening data were linked to the national cancer registry to obtain oncological follow-up. We benchmarked crude KPI results against KPI-targets set by the European guidelines and KPI results of other national screening programmes. Temporal trends were examined by plotting age-standardised KPIs against the year of screening and estimating the Average Annual Percentage Change (AAPC).

Results: PMSP coverage increased significantly over the period of 15 years (+ 7.5% AAPC), but the increase fell to + 1.6% after invitation coverage was maximised. In 2016, PMSP coverage was at 50.0% and opportunistic coverage was at 14.1%, resulting in a total coverage by screening of 64.2%. The response to the invitations was 49.8% in 2016, without a trend. Recall rate decreased significantly (AAPC -1.5% & -5.0% in initial and subsequent regular screenings respectively) while cancer detection remained stable (AAPC 0.0%). The result was an increased positive predictive value (AAPC + 3.8%). Overall programme sensitivity was stable and was at 65.1% in 2014. In initial screens of 2015, the proportion of DCIS, tumours stage II+, and node negative invasive cancers was 18.2, 31.2, and 61.6% respectively. In subsequent regular screens of 2015, those proportions were 14.0, 24.8, and 65.4% respectively. Trends were not significant.

Conclusion: Besides a suboptimal attendance rate, most KPIs in the Flemish PMSP meet EU benchmark targets. Nonetheless, there are several priorities for further investigation such as a critical evaluation of strategies to increase screening participation, organising a biennial radiological review of interval cancers, analysing the effect that preceding opportunistic screening has on the KPI for initial screenings, and efforts to estimate the impact on breast cancer mortality.

Citing Articles

Trends in socioeconomic inequalities in cause-specific premature mortality in Belgium, 1998-2019.

Otavova M, Masquelier B, Faes C, Van den Borre L, Vandeninden B, De Clercq E BMC Public Health. 2024; 24(1):470.

PMID: 38355531 PMC: 10868013. DOI: 10.1186/s12889-024-17933-z.

Relationship between health-related determinants and adherence to breast and colorectal cancer screening: a population-based study in Flanders, Belgium.

Ferrari A, Tran T, Hoeck S, Peeters M, Goossens M, Van Hal G Eur J Public Health. 2023; 34(2):347-353.

PMID: 38006217 PMC: 10990537. DOI: 10.1093/eurpub/ckad206.

The effect of a pre-scheduled appointment on attendance in a population-based mammography screening programme.

Goossens M, Kellen E, Broeders M, Vandemaele E, Jacobs B, Martens P Eur J Public Health. 2023; 33(6):1122-1127.

PMID: 37555832 PMC: 10710327. DOI: 10.1093/eurpub/ckad137.

Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review.

Selby K, Sedki M, Levine E, Kamineni A, Green B, Vachani A J Natl Cancer Inst. 2023; 115(4):375-384.

PMID: 36752508 PMC: 10086636. DOI: 10.1093/jnci/djad028.

Effectiveness of Organized Mammography Screening for Different Breast Cancer Molecular Subtypes.

Ding L, Greuter M, Truyen I, Goossens M, van der Vegt B, De Schutter H Cancers (Basel). 2022; 14(19).

PMID: 36230754 PMC: 9562677. DOI: 10.3390/cancers14194831.

References

Heidinger O, Heidrich J, Batzler W, Krieg V, Weigel S, Heindel W . Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity. Breast. 2015; 24(3):191-6. DOI: 10.1016/j.breast.2014.12.009. View

Bluekens A, Karssemeijer N, Beijerinck D, Deurenberg J, van Engen R, Broeders M . Consequences of digital mammography in population-based breast cancer screening: initial changes and long-term impact on referral rates. Eur Radiol. 2010; 20(9):2067-73. PMC: 2914257. DOI: 10.1007/s00330-010-1786-7. View

Blanks R, Moss S, Wallis M . Monitoring and evaluating the UK National Health Service Breast Screening Programme: evaluating the variation in radiological performance between individual programmes using PPV-referral diagrams. J Med Screen. 2001; 8(1):24-8. DOI: 10.1136/jms.8.1.24. View

Autier P, Boniol M, La Vecchia C, LaVecchia C, Vatten L, Gavin A . Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 2010; 341:c3620. PMC: 2920378. DOI: 10.1136/bmj.c3620. View

Goossens M, van Hal G, van der Burg M, Kellen E, Van Herck K, De Greve J . Quantifying independent risk factors for failing to rescreen in a breast cancer screening program in Flanders, Belgium. Prev Med. 2014; 69:280-6. DOI: 10.1016/j.ypmed.2014.10.019. View

Leslie W, ODonnell S, Jean S, Lagace C, Walsh P, Bancej C . Trends in hip fracture rates in Canada. JAMA. 2009; 302(8):883-9. DOI: 10.1001/jama.2009.1231. View

Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L . European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. Ann Oncol. 2007; 19(4):614-22. DOI: 10.1093/annonc/mdm481. View

Theberge I, Guertin M, Vandal N, Daigle J, Dufresne M, Wadden N . Clinical Image Quality and Sensitivity in an Organized Mammography Screening Program. Can Assoc Radiol J. 2018; 69(1):16-23. DOI: 10.1016/j.carj.2017.09.002. View

Boyer B, Canale S, Arfi-Rouche J, Monzani Q, Khaled W, Balleyguier C . Variability and errors when applying the BIRADS mammography classification. Eur J Radiol. 2012; 82(3):388-97. DOI: 10.1016/j.ejrad.2012.02.005. View

10.

SEGI M, FUJISAKU S, Kurihara M, NARAI Y, Sasajima K . The age-adjusted death rates for malignant neoplasms in some selected sites in 23 countries in 1954-1955 and their geographical correlation. Tohoku J Exp Med. 1960; 72:91-103. DOI: 10.1620/tjem.72.91. View

11.

Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E . The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012; 19 Suppl 1:14-25. DOI: 10.1258/jms.2012.012078. View

12.

Maxwell A, Beattie C, Lavelle J, Lyburn I, Sinnatamby R, Garnett S . The effect of false positive breast screening examinations on subsequent attendance: retrospective cohort study. J Med Screen. 2013; 20(2):91-8. DOI: 10.1177/0969141313499147. View

13.

Goossens M, De Brabander I, De Greve J, Vaes E, Van Ongeval C, Van Herck K . Breast cancer risk is increased in the years following false-positive breast cancer screening. Eur J Cancer Prev. 2016; 26(5):396-403. PMC: 5553233. DOI: 10.1097/CEJ.0000000000000313. View

14.

Marmot M, Altman D, Cameron D, Dewar J, Thompson S, Wilcox M . The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013; 108(11):2205-40. PMC: 3693450. DOI: 10.1038/bjc.2013.177. View

15.

Clegg L, Hankey B, Tiwari R, Feuer E, Edwards B . Estimating average annual per cent change in trend analysis. Stat Med. 2009; 28(29):3670-82. PMC: 2843083. DOI: 10.1002/sim.3733. View

16.

Henau K, van Eycken E, Silversmit G, Pukkala E . Regional variation in incidence for smoking and alcohol related cancers in Belgium. Cancer Epidemiol. 2014; 39(1):55-65. DOI: 10.1016/j.canep.2014.10.009. View

17.

Sankatsing V, Fracheboud J, de Munck L, Broeders M, van Ravesteyn N, Heijnsdijk E . Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening. BMC Cancer. 2018; 18(1):256. PMC: 5839006. DOI: 10.1186/s12885-018-4122-2. View

18.

Timmermans L, De Hauwere A, Bacher K, Bosmans H, Lemmens K, Bleyen L . Impact of the digitalisation of mammography on performance parameters and breast dose in the Flemish Breast Cancer Screening Programme. Eur Radiol. 2014; 24(8):1808-19. DOI: 10.1007/s00330-014-3169-y. View

19.

Domingo L, Hofvind S, Hubbard R, Roman M, Benkeser D, Sala M . Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain. Eur Radiol. 2015; 26(8):2520-8. PMC: 4927608. DOI: 10.1007/s00330-015-4074-8. View